Novo Nordisk (NVO)

• Market cap: $195B
• 1 day: 3.93%
• 5 days: 7.65%
• 1 month: 20.29%
• 3 months: -25.54%
• 6 months: -10.65%
• Year to date: -16.24%
• 1 year: -33.11%
• 5 years: 16.49%
• 10 years: 57.11%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Employees: 69,500